Eledon Pharmaceuticals OverviewEledon Pharmaceuticals Other Income Expense Net
Other Income/Expense Net for ELDN.
Quarterly Other Income/Expense
-$17.84M
↓ 255.58% YoY
As of Mar 31, 2026
Annual Other Income/Expense (TTM)
$8.36M
↓ 85.8% YoY
Trailing 12 months ending Mar 31, 2026